Maeva Guillaume researcher ORCID ID = 0000-0002-2782-7556
Guillaume, Maeva, 1982-....
VIAF ID: 290920869 (Personal)
Permalink: http://viaf.org/viaf/290920869
Preferred Forms
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
The Activation Function-1 of Estrogen Receptor Alpha Prevents Arterial Neointima Development Through a Direct Effect on Smooth Muscle Cells. | |
The antagonist properties of Bazedoxifene after acute treatment are shifted to stimulatory action after chronic exposure in the liver but not in the uterus | |
Bleeding risk of variceal band ligation in extrahepatic portal vein obstruction is not increased by oral anticoagulation. | |
Central obesity is associated with non-cirrhotic portal vein thrombosis | |
Clinical characteristics and outcome of cirrhotic patients with high protein concentrations in ascites: a prospective study. | |
Direct comparison of the specialised blood fibrosis tests FibroMeterV2G and Enhanced Liver Fibrosis score in patients with non-alcoholic fatty liver disease from tertiary care centres | |
Effect of chronic estradiol plus progesterone treatment on experimental arterial and venous thrombosis in mouse. | |
Estrogen receptor subcellular localization and cardiometabolism | |
Etude des mécanismes moléculaires impliqués dans l'effet hépatique des œstrogènes dans la perspective de prévenir les hépatopathies métaboliques | |
Étude prospective du microbiote intestinal et sanguin chez des patients atteints de stéatopathie métabolique | |
Grazoprevir plus elbasvir in HCV genotype-1 or -4 infected patients with stage 4/5 severe chronic kidney disease is safe and effective. | |
Is there evidence for stopping anticoagulation therapy before endoscopic variceal ligation? | |
New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD | |
Une nouvelle entité clinique : l'ascite riche en protides au cours de la cirrhose | |
Nuclear and Membrane Actions of Estrogen Receptor Alpha: Contribution to the Regulation of Energy and Glucose Homeostasis. | |
Pharmacological agents for nonalcoholic steatohepatitis. | |
Progressive multifocal leukoencephalopathy in a patient with alcoholic cirrhosis. | |
Prospective clinical study of gut and blood microbiota in NAFLD patients. | |
A Prospective Study Identifying Predictive Factors of Cardiac Decompensation After Transjugular Intrahepatic Portosystemic Shunt: The Toulouse Algorithm | |
Protective Hematopoietic Effect of Estrogens in a Mouse Model of Thrombosis: Respective Roles of Nuclear Versus Membrane Estrogen Receptor α | |
Role of ERαMISS in the Effect of Estradiol on Cancellous and Cortical Femoral Bone in Growing Female Mice | |
Selective Liver Estrogen Receptor α Modulation Prevents Steatosis, Diabetes, and Obesity Through the Anorectic Growth Differentiation Factor 15 Hepatokine in Mice | |
Should the Presence of Spontaneous Portosystemic Shunts Be Implemented to the Model for End-Stage Liver Disease Score for a Better Prediction of Outcome? | |
Study of the molecular mechanisms involved in the hepatic effect of estrogens : interest in the prevention of metabolic liver diseases. | |
Towards optimization of estrogen receptor modulation in medicine |